Education Session
606 - 21st Century Approaches for Reducing
Manufacturing Costs During a Global Economic
Crisis
11 November 12.45-15.45
ISPE CEUs: 0.25
Tracks: SurvivalProduct
Times of economic crisis present opportunities to streamline operations and implement cost saving technologies. A recent Georgetown University report confirms that there are billions of dollars to be recouped by modernizing pharmaceutical manufacturing operations and reducing non-value-added practices. Principles of lean manufacturing, operational excellence, and innovative manufacturing technologies can improve manufacturing efficiency and lower the cost of production. While other sessions at Annual Meeting will look at some of these issues in detail, this session will overview a number of opportunities to consider.
In this session we will specifically focus on:
- Reducing capital investment through disposables
- Learning from lean contract manufacturers – how do they do things more economically?
- Continuous processing to reduce foot print, equipment costs while debottlenecking downstream operations
- How recent risk-based regulatory guidance (E 2500, ICH Q9) can streamline the qualification process and lower start-up costs
Who Should Attend
Professionals from manufacturing operations, engineering, quality assurance, and finance
Session Leader
- Peter Watler, PhD, Principal Consultant, Hyde Engineering + Consulting Inc USA
Session Presenters
- Robert Bettis, West Coast Director, Hyde Engineering + Consulting USA
- Tim Matthews, Sr Engineer, Genentech USA
- Andrew Ramelmeier, Ph.D., VP Manufacturing, Process Development & Facilities, BioMarin USA
- Michiel Ultee, Vice President, Process Sciences, Laureate Pharma, Inc. USA